Kinnate Biopharma Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Kinnate Biopharma Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q4 2023.
  • Kinnate Biopharma Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2023 was 47.1M shares, a 6.27% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 47.1M +2.78M +6.27% Dec 31, 2023 10-K 2024-03-28
Q3 2023 47.1M +2.95M +6.68% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 47.1M +2.95M +6.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 46.6M +2.61M +5.95% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 44.3M +486K +1.11% Dec 31, 2022 10-K 2024-03-28
Q3 2022 44.2M +482K +1.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 44.1M +474K +1.09% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 44M +479K +1.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 43.9M +379K +0.87% Dec 31, 2021 10-K 2023-03-15
Q3 2021 43.7M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 43.6M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 43.5M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 43.5M Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.